Treace Medical completes first surgery with new HyperPlate XM implant
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 7/15/2026
- Wall St futures tick up as investors weigh earnings; PayPal jumps
- PayPal rallies 20% on report Stripe, Advent made $53 billion bid
- Oil prices rise 1% as hostilities worsen in the Middle East
- ASML capacity upgrade soothes AI chip bottleneck fears
- Dollar steadies as Middle East escalation counters soft US inflation
- IBM misses Q2 targets as mainframe and software sales disappoint
- Verizon planning new round of layoffs this week - Barron’s
- Kosovo bans Serb minister over ethnic cleansing remarks
- Lucid Group shares quickly cut in half on report of potential bankruptcy
- S&P 500 and Nasdaq end higher on cool inflation data, solid bank earnings
Treace Announces First Surgical Case with the HyperPlate™ XM Dynamic Compression Locking Implant System
June 18, 2026 7:05 AM EDTNew portfolio addition to drive further penetration into incremental procedures throughout the foot and ankle; strengthens Treaces comprehensive suite of technologies for its growing customer base
PONTE VEDRA, Fla., June 18, 2026 (GLOBE NEWSWIRE) -- Treace Medical Concepts, Inc. (Treace or the Company) (Nasdaq: TMCI), a medical technology company driving a fundamental shift in the surgical treatment of bunions and related midfoot deformities, today announced the successful completion of the first case utilizing its HyperPlate XM Dynamic Compression Locking Implant.
HyperPlate fixation technology further advances the SpeedPlate® implant platform by incorporating... More
